Virtue Capital Management LLC bought a new position in Humana Inc. (NYSE:HUM – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,613 shares of the insurance provider’s stock, valued at approximately $1,379,000.
A number of other institutional investors have also recently bought and sold shares of HUM. Greenleaf Trust raised its position in shares of Humana by 1.7% in the 3rd quarter. Greenleaf Trust now owns 2,524 shares of the insurance provider’s stock worth $963,000 after buying an additional 41 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Humana during the third quarter worth about $14,054,000. ProShare Advisors LLC increased its stake in Humana by 1.9% during the third quarter. ProShare Advisors LLC now owns 19,489 shares of the insurance provider’s stock worth $7,436,000 after acquiring an additional 364 shares during the last quarter. Vise Technologies Inc. increased its stake in Humana by 18.1% during the third quarter. Vise Technologies Inc. now owns 2,908 shares of the insurance provider’s stock worth $1,110,000 after acquiring an additional 445 shares during the last quarter. Finally, Cidel Asset Management Inc. raised its holdings in shares of Humana by 1.3% in the 3rd quarter. Cidel Asset Management Inc. now owns 3,935 shares of the insurance provider’s stock worth $1,501,000 after purchasing an additional 52 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on HUM. Oppenheimer boosted their target price on Humana from $475.00 to $525.00 and gave the stock an “outperform” rating in a report on Monday, October 12th. Piper Sandler upgraded shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target on the stock in a report on Thursday, July 30th. Cantor Fitzgerald raised shares of Humana from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $300.00 to $460.00 in a research report on Wednesday, October 7th. Bank of America upgraded shares of Humana from a “neutral” rating to a “buy” rating and set a $500.00 price objective for the company in a research note on Wednesday, July 29th. Finally, TD Cowen increased their price objective on shares of Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a research report on Friday, July 31st. Twenty-one investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $453.30.
Check Out Our Latest Report on Humana
Humana Stock Down 0.1%
NYSE HUM opened at $414.04 on Monday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $456.50. The business has a 50 day moving average price of $400.92 and a two-hundred day moving average price of $308.70. The stock has a market cap of $49.72 billion, a PE ratio of 39.17, a P/E/G ratio of 2.55 and a beta of 0.74.
Humana Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 24th will be paid a $0.8850 dividend. The ex-dividend date is Thursday, December 24th. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. Humana’s dividend payout ratio is 33.49%.
About Humana
Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.
Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.
Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.
Recommended Stories
- Five stocks we like better than Humana
- STMicroelectronics Could Reach New Highs—Here’s What Needs to Happen
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
